Skip to main content
Year archive

Genscript Biotech Corporation — 2025 filings

All 69 regulatory filings released by Genscript Biotech Corporation (1548) in 2025, sourced directly from the official regulator.

69 Filings
2025 Period
2025 filings (69)
Filing Released Lang
GRANT OF SHARE AWARDS
Share Issue/Capital Change
2025-12-16 English
2021 Restricted Share Unit Scheme
Governance Information
2025-12-16 English
2019 Restricted Share Unit Scheme
Governance Information
2025-12-16 English
AMENDMENT TO THE 2019 RESTRICTED SHARE UNIT SCHEME AND THE 2021 RESTRICTED SHARE UNIT SCHEME
Share Issue/Capital Change
2025-12-15 English
VOLUNTARY ANNOUNCEMENT: LEGEND ANNOUNCES PRESENTATIONS AT THE 2025 ASH ANNUAL MEETING
Regulatory Filings
2025-12-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Share Issue/Capital Change
2025-12-02 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-11-20 English
VOLUNTARY ANNOUNCEMENT: FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED 30 SEPTEMBER 2025 OF A LISTED ASSOCIATE - LEGEND BIOTECH CORPORATION
Report Publication Announcement
2025-11-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Share Issue/Capital Change
2025-11-04 English
VOLUNTARY ANNOUNCEMENT: LEGEND WILL PRESENT NEW DATA AT THE AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING
Regulatory Filings
2025-11-04 English
VOLUNTARY ANNOUNCEMENT: LEGEND ANNOUNCES PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED 30 SEPTEMBER 2025
Regulatory Filings
2025-10-14 English
INSIDE INFORMATION ANNOUNCEMENT - PROBIO RECEIVED PAYMENTS UNDER THE LICENSE AGREEMENT WITH LANOVA MEDICINES LTD.
Regulatory Filings
2025-10-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Share Issue/Capital Change
2025-10-03 English
GRANT OF SHARE AWARDS
Director's Dealing
2025-09-21 English
INTERIM REPORT 2025
Regulatory Filings
2025-09-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
Share Issue/Capital Change
2025-09-03 English
ANNOUNCEMENT OF UNAUDITED CONSOLIDATED INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2025
Interim / Quarterly Report H2 2025
2025-08-17 English
VOLUNTARY ANNOUNCEMENT: FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2025 OF A LISTED ASSOCIATE - LEGEND BIOTECH CORPORATION
Report Publication Announcement
2025-08-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
Share Issue/Capital Change
2025-08-05 English
DATE OF BOARD MEETING
Regulatory Filings
2025-08-04 English
INSIDE INFORLATION: POSITIVE PROFIT ALERT
Earnings Release H2 2025
2025-07-22 English
VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED 30 JUNE 2025
Earnings Release Q2 2025
2025-07-16 English
Next Day Disclosure Return
Transaction in Own Shares
2025-07-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
Share Issue/Capital Change
2025-07-07 English
INSIDE INFORMATION ANNOUNCEMENT - PROBIO RECEIVED PAYMENTS UNDER THE LICENSE AGREEMENT WITH LANOVA MEDICINES LTD.
Regulatory Filings
2025-06-30 English
GRANT OF RESTRICTED SHARES
Share Issue/Capital Change
2025-06-11 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-06-10 English
VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCED NEW 5-YEAR SURVIVAL DATA FOR CARVYKTI IN CARTITUDE-1 STUDY FOR MULTIPLE MYELOMA AT 2025 ASCO ANNUAL MEETING
Regulatory Filings
2025-06-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
Share Issue/Capital Change
2025-06-04 English
Nomination Committee -Terms of Reference
Governance Information
2025-05-29 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Governance Information
2025-05-29 English
(1) POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 29 MAY 2025&#x3b; (2) CHANGE IN COMPOSITION OF THE BOARD&#x3b; AND (3) CHANGE IN COMPOSITION OF BOARD COMMITTEES
Declaration of Voting Results & Voting Rights Announcements
2025-05-29 English
VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH WILL PRESENT NEW DATA ON CARVYKTI FOR PATIENTS WITH MULTIPLE MYELOMA AT 2025 ASCO AND EHA ANNUAL MEETINGS
Report Publication Announcement
2025-05-23 English
Next Day Disclosure Return
Transaction in Own Shares
2025-05-21 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-05-20 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-05-16 English
VOLUNTARY ANNOUNCEMENT: FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2025 OF A LISTED ASSOCIATE - LEGEND BIOTECH CORPORATION
Report Publication Announcement
2025-05-13 English
COMPLETION OF DISCLOSEABLE TRANSACTION AND TRANSACTION WITH CONNECTED PERSON AT SUBSIDIARY LEVEL IN RELATION TO TRANSFER OF SHARES OF PROBIO CAYMAN
M&A Activity
2025-05-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
Regulatory Filings
2025-05-07 English
DISCLOSEABLE TRANSACTION AND TRANSACTION WITH CONNECTED PERSON AT SUBSIDIARY LEVEL IN REATION TO TRANSFER OF SHARES OF PROBIO CAYMAN
Capital/Financing Update
2025-04-28 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-04-24 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-04-23 English
(REVISED) Next Day Disclosure Returns
Share Issue/Capital Change
2025-04-16 English
VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED 31 MARCH 2025
Regulatory Filings
2025-04-15 English
Next Day Disclosure Returns
Share Issue/Capital Change
2025-04-14 English
Notification Letter to Non-Registered Shareholders and Reply Form - Reminder letter regarding the arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings
2025-04-08 English
Notification Letter to Registered Shareholders and Reply Form - Reminder letter regarding the arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings
2025-04-08 English
FORM OF PROXY FOR 2025 ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2025-04-08 English
PROPOSALS FOR GRANTING OF GENERAL MANDATES TO ISSUE NEW SHARES AND TO REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2025-04-08 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2025-04-08 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024
Environmental & Social Information
2025-04-08 English
ANNUAL REPORT 2024
Annual Report FY 2024
2025-04-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
Regulatory Filings
2025-04-07 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-03-18 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-03-14 English
SUPPLEMENTAL ANNOUNCEMENT TO THE INSIDE INFORMATION ANNOUNCEMENT: FINANCIAL RESULTS FOR FOURTH QUARTER AND THE YEAR ENDED DECEMBER 31, 2024 OF A LISTED ASSOCIATE -LEGEND BIOTECH CORPORATION
Earnings Release Q4 2024
2025-03-14 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
Earnings Release FY 2024
2025-03-11 English
INSIDE INFORMATION: FINANCIAL RESULTS FOR FOURTH QUARTER AND THE YEAR ENDED DECEMBER 31, 2024 OF A LISTED ASSOCIATE - LEGEND BIOTECH CORPORATION
Earnings Release Q4 2024
2025-03-11 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Governance Information
2025-03-11 English
REDESIGNATION OF DIRECTOR AND CHANGE OF COMPOSITION OF COMMITTEE
Board/Management Information
2025-03-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
Share Issue/Capital Change
2025-03-04 English
DATE OF BOARD MEETING
Report Publication Announcement
2025-02-27 English
INSIDE INFORLATION: POSITIVE PROFIT ALERT
Regulatory Filings
2025-02-16 English
Risk Management and ESG Committee - Terms of Reference
Governance Information
2025-02-14 English
ESTABLISHMENT OF A SUB-COMMITTEE OF THE RISK MANAGEMENT AND ESG COMMITTEE
Governance Information
2025-02-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
Share Issue/Capital Change
2025-02-05 English
VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED 31 DECEMBER 2024
Earnings Release Q4 2024
2025-01-22 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-01-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
Share Issue/Capital Change
2025-01-03 English